Innovative Eyewear Inc (LUCYW) Financial Statements (2026 and earlier)

Company Profile

Business Address 11900 BISCAYNE BLVD
MIAMI, FL 33181
State of Incorp. FL
Fiscal Year End December 31
Industry (SIC) 3851 - Ophthalmic Goods (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,5117,5244,2873,591
Cash and cash equivalent6,5112,6294,2873,591
Short-term investments  4,895  
Receivables14210893110
Inventory, net of allowances, customer advances and progress billings1,74583253395
Inventory1,74583253395
Prepaid expense264267314211
Other current assets0595936
Other undisclosed current assets773448330198
Total current assets:9,4359,2385,6174,241
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization62108133120
Intangible asset, including goodwill, after accumulated amortization560451286138
Intangible asset, excluding goodwill, after accumulated amortization560451286138
Other noncurrent assets83417382
Other undisclosed noncurrent assets   110110
Total noncurrent assets:705600602449
TOTAL ASSETS:10,1409,8386,2194,690
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:985693582276
Other undisclosed accounts payable and accrued liabilities985693582276
Deferred revenue60454330
Debt    61
Other undisclosed current liabilities   233
Total current liabilities:1,045738624600
Noncurrent Liabilities
Liabilities, other than long-term debt  53565
Deferred revenue  53565
Other undisclosed noncurrent liabilities28   
Total noncurrent liabilities:2853565
Total liabilities:1,074743660665
Equity
Equity, attributable to parent9,0669,0955,5594,024
Common stock0000
Additional paid in capital41,39333,83122,52814,330
Accumulated deficit(32,327)(24,736)(16,969)(10,306)
Total equity:9,0669,0955,5594,024
TOTAL LIABILITIES AND EQUITY:10,1409,8386,2194,690

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Revenues2,6621,6361,152660
Cost of revenue(2,094)(1,421)(1,272)(716)
Gross profit:567215(119)(56)
Operating expenses(9,062)(8,139)(6,736)(5,520)
Operating loss:(8,495)(7,924)(6,856)(5,577)
Nonoperating income904157192 
Other nonoperating income  157195 
Interest and debt expense   (3)(105)
Loss from continuing operations before income taxes:(7,591)(7,767)(6,666)(5,682)
Income tax benefit    
Loss from continuing operations:(7,591)(7,767)(6,666)(5,682)
Other undisclosed net income (loss)  3 
Net loss available to common stockholders, diluted:(7,591)(7,767)(6,663)(5,682)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Net loss:(7,591)(7,767)(6,663)(5,682)
Comprehensive loss, net of tax, attributable to parent:(7,591)(7,767)(6,663)(5,682)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: